Page last updated: 2024-09-04

methyl 5-aminolevulinate and Minimal Disease, Residual

methyl 5-aminolevulinate has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I	1

Other Studies

1 other study(ies) available for methyl 5-aminolevulinate and Minimal Disease, Residual

Article	Year
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. The British journal of dermatology, 2014, Volume: 170, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2014

Article

Year

Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.

The British journal of dermatology, 2014, Volume: 170, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome

2014